FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year Earnings Per Share History
[Consolidated]
| Mar2025 | |
|---|---|
| Earnings Per Share (Rs) | 41.80 |
What is the latest Earnings Per Share ratio of FREDUN PHARMACEUTICALS ?
| Year | Earnings Per Share |
|---|---|
| Mar2025 | 41.80 |
How is Earnings Per Share of FREDUN PHARMACEUTICALS Trending?
| Years | Earnings Per Share | % Change | |
|---|---|---|---|
| Mar2025 | 41.8 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Earnings Per Share ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,390.9 Cr | 9.8% | 21.3% | 260.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 9.8% |
21.3% |
260.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses